News

Ophthalmology Times5d
Study data link cannabis use to lower risk of proliferative vitreoretinopathy after retinal detachment repair
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...
Modern Retina5d
FDA agrees to expand Atsena's gene therapy trial for XLRS treatment
Atsena Therapeutics expands its ATSN-201 trial for X-linked retinoschisis, a step toward the first gene therapy treatment.